002728 特一药业
交易中 02-10 11:02:09
资讯
新帖
简况
异动快报：特一药业（002728）2月6日9点51分触及涨停板
证券之星 · 02-06
异动快报：特一药业（002728）2月6日9点51分触及涨停板
异动快报：特一药业（002728）1月26日9点55分触及涨停板
证券之星 · 01-26
异动快报：特一药业（002728）1月26日9点55分触及涨停板
特一药业：预计2025年全年每股收益盈利:0.14元至0.18元
证券之星 · 01-22
特一药业：预计2025年全年每股收益盈利:0.14元至0.18元
特一药业(002728.SZ)发预增，预计2025年度归母净利润7000万元—9000万元，同比增长241.55%—339.13%
智通财经 · 01-22
特一药业(002728.SZ)发预增，预计2025年度归母净利润7000万元—9000万元，同比增长241.55%—339.13%
股市必读：特一药业（002728）1月15日董秘有最新回复
证券之星 · 01-16
股市必读：特一药业（002728）1月15日董秘有最新回复
特一药业：止咳宝片对慢性咳嗽临控+显效率达73%
证券之星 · 01-15
特一药业：止咳宝片对慢性咳嗽临控+显效率达73%
特一药业：暂未布局中药+脑机接口业务
证券之星 · 01-09
特一药业：暂未布局中药+脑机接口业务
特一药业：2025年前三季度净利润同比增长985.18%
证券之星 · 01-09
特一药业：2025年前三季度净利润同比增长985.18%
特一药业：止咳宝片研究已有阶段性成果
证券之星 · 01-09
特一药业：止咳宝片研究已有阶段性成果
特一药业涨5.07%，华安证券一个月前给出“买入”评级
证券之星 · 01-05
特一药业涨5.07%，华安证券一个月前给出“买入”评级
股市必读：特一药业（002728）12月31日董秘有最新回复
证券之星 · 01-05
股市必读：特一药业（002728）12月31日董秘有最新回复
流感疫情持续，防控系统工程再受考验
证券之星 · 2025-12-31
流感疫情持续，防控系统工程再受考验
特一药业：公司没有禽流感的特效药
证券之星 · 2025-12-31
特一药业：公司没有禽流感的特效药
特一药业：中成药与化学药研发双向并举
证券之星 · 2025-12-26
特一药业：中成药与化学药研发双向并举
特一药业（002728）披露部分募投项目延期公告，12月23日股价上涨0.63%
证券之星 · 2025-12-23
特一药业（002728）披露部分募投项目延期公告，12月23日股价上涨0.63%
特一药业：中成药和化学药研发双向并举
证券之星 · 2025-12-22
特一药业：中成药和化学药研发双向并举
11月27日特一药业（002728）龙虎榜数据：机构净卖出577.06万元，北向资金净买入678.93万元
中金财经 · 2025-11-27
11月27日特一药业（002728）龙虎榜数据：机构净卖出577.06万元，北向资金净买入678.93万元
特一药业最新公告：公司经营正常不存在应披露而未披露的重大事项
证券之星 · 2025-11-27
特一药业最新公告：公司经营正常不存在应披露而未披露的重大事项
异动快报：特一药业（002728）11月27日14点37分触及涨停板
证券之星 · 2025-11-27
异动快报：特一药业（002728）11月27日14点37分触及涨停板
11月26日特一药业（002728）龙虎榜数据：机构净买入1593.85万元，北向资金净卖出682.58万元
证券之星 · 2025-11-26
11月26日特一药业（002728）龙虎榜数据：机构净买入1593.85万元，北向资金净卖出682.58万元
加载更多
公司概况
公司名称：
特一药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2014-07-31
主营业务：
特一药业集团股份有限公司的主营业务是中成药品、化学制剂药品、化学原料药的研发、生产和销售。公司的主要产品包括止咳宝片、感冒灵颗粒、血塞通分散片、银杏叶分散片、益心舒颗粒、铝碳酸镁咀嚼片、枫蓼肠胃康片、奥美拉唑肠溶胶囊、皮肤病血毒丸、小儿咳喘灵颗粒、金匮肾气片、降糖舒丸、独活寄生颗粒等。
发行价格：
14.00
{"stockData":{"symbol":"002728","market":"SZ","secType":"STK","nameCN":"特一药业","latestPrice":13.05,"timestamp":1770692529000,"preClose":13.08,"halted":0,"volume":32370708,"delay":0,"changeRate":-0.0023,"floatShares":377000000,"shares":513000000,"eps":0.1554,"marketStatus":"交易中","change":-0.03,"latestTime":"02-10 11:02:09","open":12.95,"high":13.31,"low":12.9,"amount":424000000,"amplitude":0.0313,"askPrice":13.06,"askSize":124,"bidPrice":13.05,"bidSize":439,"shortable":0,"etf":0,"ttmEps":0.1554,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1770694200000},"marketStatusCode":2,"adr":0,"adjPreClose":13.08,"symbolType":"stock","openAndCloseTimeList":[[1770687000000,1770694200000],[1770699600000,1770706800000]],"highLimit":14.39,"lowLimit":11.77,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":513002496,"isCdr":false,"pbRate":3.72,"roa":"--","peRate":83.976834,"roe":"3.65%","epsLYR":0.04,"committee":0.39256,"marketValue":6695000000,"turnoverRate":0.0859,"status":1,"floatMarketCap":4917000000},"requestUrl":"/m/hq/s/002728","defaultTab":"news","newsList":[{"id":"2609253754","title":"异动快报：特一药业（002728）2月6日9点51分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2609253754","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609253754?lang=zh_cn&edition=full","pubTime":"2026-02-06 09:55","pubTimestamp":1770342924,"startTime":"0","endTime":"0","summary":"证券之星2月6日盘中消息，9点51分特一药业触及涨停板。其所属行业中药目前上涨。领涨股为振东制药。该股为中药，长寿药NMN，流感概念热股，当日中药概念上涨1.78%，长寿药NMN概念上涨1.21%，流感概念上涨0.89%。2月5日的资金流向数据方面，主力资金净流入1203.54万元，占总成交额3.31%，游资资金净流入125.5万元，占总成交额0.34%，散户资金净流出1329.04万元，占总成交额3.65%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600010279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"gpt_icon":0},{"id":"2606602267","title":"异动快报：特一药业（002728）1月26日9点55分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2606602267","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606602267?lang=zh_cn&edition=full","pubTime":"2026-01-26 10:01","pubTimestamp":1769392872,"startTime":"0","endTime":"0","summary":"证券之星1月26日盘中消息，9点55分特一药业（002728）触及涨停板。其所属行业中药目前下跌。领涨股为康惠股份。该股为流感，长寿药NMN，新冠病毒防治概念热股，当日流感概念上涨1.19%，长寿药NMN概念上涨0.59%。1月23日的资金流向数据方面，主力资金净流入652.82万元，占总成交额1.1%，游资资金净流入157.72万元，占总成交额0.26%，散户资金净流出810.55万元，占总成交额1.36%。近5日资金流向一览见下表：特一药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600005420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"gpt_icon":0},{"id":"2605346237","title":"特一药业：预计2025年全年每股收益盈利:0.14元至0.18元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605346237","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605346237?lang=zh_cn&edition=full","pubTime":"2026-01-22 18:01","pubTimestamp":1769076101,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业发布业绩预告，预计2025年全年每股收益盈利:0.14元至0.18元。特一药业2025年三季报显示，前三季度公司主营收入6.92亿元，同比上升51.86%；归母净利润6521.71万元，同比上升985.18%；扣非净利润6280.97万元，同比上升2508.06%；其中2025年第三季度，公司单季度主营收入2.01亿元，同比上升41.49%；单季度归母净利润2720.94万元，同比上升719.47%；单季度扣非净利润2472.44万元，同比上升1278.5%；负债率18.81%，投资收益74.87万元，财务费用166.38万元，毛利率56.94%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200030144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002728"],"gpt_icon":0},{"id":"2605466272","title":"特一药业(002728.SZ)发预增，预计2025年度归母净利润7000万元—9000万元，同比增长241.55%—339.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605466272","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605466272?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:46","pubTimestamp":1769071591,"startTime":"0","endTime":"0","summary":"智通财经APP讯，特一药业(002728.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润7000万元—9000万元，同比增长241.55%—339.13%;扣除非经常性损益后的净利润6750万元—8750万元，同比增长263.83%—371.64%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"特一药业(002728.SZ)发预增，预计2025年度归母净利润7000万元—9000万元，同比增长241.55%—339.13%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002728"],"gpt_icon":0},{"id":"2603982995","title":"股市必读：特一药业（002728）1月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603982995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603982995?lang=zh_cn&edition=full","pubTime":"2026-01-16 01:13","pubTimestamp":1768497188,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘，特一药业报收于11.45元，下跌1.97%，换手率7.01%，成交量26.42万手，成交额3.03亿元。董秘最新回复投资者： 最新的鼻病毒，贵公司有无针对的药物董秘： 您好，感谢您对公司的关注。目前，针对鼻病毒本身尚无特效抗病毒药物，临床以对症治疗为主。建议消费者应当根据实际情况遵照医嘱用药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600000570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2603679417","title":"特一药业：止咳宝片对慢性咳嗽临控+显效率达73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603679417","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603679417?lang=zh_cn&edition=full","pubTime":"2026-01-15 15:04","pubTimestamp":1768460653,"startTime":"0","endTime":"0","summary":"鼻病毒是引起普通感冒最常见的病原体，表现主要为鼻塞、流涕、咳嗽、咽痛及发热等上呼吸道症状。目前，针对鼻病毒本身尚无特效抗病毒药物，临床以对症治疗为主。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500019251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2602474853","title":"特一药业：暂未布局中药+脑机接口业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2602474853","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602474853?lang=zh_cn&edition=full","pubTime":"2026-01-09 15:00","pubTimestamp":1767942036,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业(002728)01月09日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司有脑机接口的技术相关储备没。中药脑机接口特一药业回复：您好，感谢您对公司的关注。公司目前暂未布局“中药+脑机接口”相关业务，但会持续关注该领域技术发展动态。未来若有相关业务规划，公司将严格按照信息披露规则及时履行公告义务。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900018708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2602170347","title":"特一药业：2025年前三季度净利润同比增长985.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602170347","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602170347?lang=zh_cn&edition=full","pubTime":"2026-01-09 15:00","pubTimestamp":1767942036,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业01月09日在投资者关系平台上答复投资者关心的问题。2025年前三季度，公司实现营业总收入6.92亿元，同比增长51.86%；实现归属于上市公司股东的净利润6,521.71万元，同比增长985.18%。核心产品“特一”牌止咳宝片的销售稳步恢复，前三季度销量已恢复至2023年同期的64%，线上业务拓展也取得了积极成效。基于前三季度的经营态势，公司2025年年度经营情况符合内部规划预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900018711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"gpt_icon":0},{"id":"2602474873","title":"特一药业：止咳宝片研究已有阶段性成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2602474873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602474873?lang=zh_cn&edition=full","pubTime":"2026-01-09 15:00","pubTimestamp":1767942035,"startTime":"0","endTime":"0","summary":"请问公司止咳宝片是否已开展医保申报的前期准备，比如临床数据梳理、竞品申报路径对标分析？公司核心产品止咳宝片具有百年历史，具有“宣肺祛痰、止咳平喘”之功效。近年来，公司已对止咳宝片治疗流感病毒感染后咳嗽及肺部炎症的药效机制和物质基础进行了研究，以及对止咳宝片在药理毒理、依赖性等方面进行了研究。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900018707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2601800506","title":"特一药业涨5.07%，华安证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601800506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601800506?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:43","pubTimestamp":1767598995,"startTime":"0","endTime":"0","summary":"今日特一药业（002728）涨5.07%，收盘报11.4元。2025年11月18日，华安证券研究员谭国超发布了对特一药业的研报《营销体系改革完成，止咳宝片持续放量》，该研报对特一药业给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为42.51%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为光大证券的王明瑞。特一药业（002728）个股概况：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","600909"],"gpt_icon":0},{"id":"2601029338","title":"股市必读：特一药业（002728）12月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601029338","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601029338?lang=zh_cn&edition=full","pubTime":"2026-01-05 02:00","pubTimestamp":1767549646,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，特一药业报收于10.85元，下跌1.09%，换手率4.72%，成交量17.8万手，成交额1.94亿元。董秘最新回复投资者： 对于禽流感，贵公司有无特效药？公司没有禽流感的特效药。针对该症状来看，公司药品涵盖了止咳、退热、抗生素、抗病毒药等类别。当日关注点来自交易信息汇总：12月31日主力资金净流出2464.3万元，占总成交额12.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500000611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002728"],"gpt_icon":0},{"id":"2595127727","title":"流感疫情持续，防控系统工程再受考验","url":"https://stock-news.laohu8.com/highlight/detail?id=2595127727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595127727?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:18","pubTimestamp":1767172695,"startTime":"0","endTime":"0","summary":"2025年末，全国流感疫情持续处于高流行水平。产业链协同响应，构建多层次供应保障流感防控是一项系统工程，需要疫苗预防、快速诊断、药物治疗等多个环节的有效衔接。本轮疫情中，上市药企正通过全产业链布局，搭建从源头预防到终端治疗的健康保障网络。中成药在本轮疫情中表现活跃。公司表示，金振口服液四季度市场需求回暖，正加紧排产满足市场需要。随着该产品儿童流感新适应症的获批，其在儿科领域的应用场景进一步拓宽。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025123100030908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0077","000756","600557","002728","600079","BK0012","BK0236","002317","BK0096","002393","BK0197","BK0239","BK0097","002603","000999","BK0196","BK0074","BK0188","300937","BK0250","BK0175","603858","BK0086","BK0185","300244","603882","BK0042","SG9999001069.SGD","301207","600566","BK0046","BK0187","BK0060","BK0010","BK0164","BK0284","BK0070","BK0183","BK0201","BK0146","000623","BK0114","688276","BK0028"],"gpt_icon":0},{"id":"2595724322","title":"特一药业：公司没有禽流感的特效药","url":"https://stock-news.laohu8.com/highlight/detail?id=2595724322","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595724322?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:06","pubTimestamp":1767168372,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业12月31日在投资者关系平台上答复投资者关心的问题。公司没有禽流感的特效药。针对上述症状，公司有丰富的产品线，涵盖止咳、退热、抗生素、抗病毒及消化系统用药等多个类别，可全面满足对症治疗需求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100024277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"gpt_icon":0},{"id":"2594252022","title":"特一药业：中成药与化学药研发双向并举","url":"https://stock-news.laohu8.com/highlight/detail?id=2594252022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594252022?lang=zh_cn&edition=full","pubTime":"2025-12-26 08:33","pubTimestamp":1766709184,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业12月25日在投资者关系平台上答复投资者关心的问题。或者创新药目前进行到那一步了特一药业回复：您好，感谢您对公司的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600004039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"gpt_icon":0},{"id":"2593155994","title":"特一药业（002728）披露部分募投项目延期公告，12月23日股价上涨0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593155994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593155994?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:18","pubTimestamp":1766499533,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘，特一药业报收于11.24元，较前一交易日上涨0.63%，最新总市值为57.66亿元。该股当日开盘11.18元，最高11.36元，最低10.93元，成交额达4.29亿元，换手率为10.18%。近日，特一药业发布公告称，公司于2025年12月23日召开第六届董事会第五次会议，审议通过《关于部分募投项目延期的议案》。公司决定将“药品仓储物流中心及信息系统建设项目”达到预定可使用状态日期由2025年12月31日延期至2026年12月31日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300040147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"gpt_icon":0},{"id":"2593108139","title":"特一药业：中成药和化学药研发双向并举","url":"https://stock-news.laohu8.com/highlight/detail?id=2593108139","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593108139?lang=zh_cn&edition=full","pubTime":"2025-12-22 11:33","pubTimestamp":1766374387,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业12月22日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200008495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2586249165","title":"11月27日特一药业（002728）龙虎榜数据：机构净卖出577.06万元，北向资金净买入678.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586249165","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586249165?lang=zh_cn&edition=full","pubTime":"2025-11-27 18:03","pubTimestamp":1764237802,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月27日公布的交易公开信息显示，特一药业因日涨幅偏离值达到7%的前5只证券，连续三个交易日内，涨幅偏离值累计达到20%的证券，日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年11月27日收盘，特一药业报收于14.97元，上涨9.99%，涨停，换手率36.39%，成交量137.13万手，成交额19.19亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出577.06万元，北向资金合计净买入678.93万元。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202511/27/20251127215995.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202511/27/20251127215995.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251127/31828837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002728","BK0239","BK0201"],"gpt_icon":0},{"id":"2586246954","title":"特一药业最新公告：公司经营正常不存在应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2586246954","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586246954?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:43","pubTimestamp":1764236584,"startTime":"0","endTime":"0","summary":"特一药业公告称，公司股票连续三个交易日内收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动的情况。经核实，公司经营正常，近期公司经营情况、内外部经营环境未发生重大变化。公司前期所披露的信息不存在需要更正、补充之处。公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较大影响的未公开重大信息。公司、控股股东和实际控制人不存在关于本公司的应披露而未披露的重大事项，不存在处于筹划阶段的重大事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700025927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002728","BK0239"],"gpt_icon":0},{"id":"2586214522","title":"异动快报：特一药业（002728）11月27日14点37分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2586214522","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586214522?lang=zh_cn&edition=full","pubTime":"2025-11-27 14:40","pubTimestamp":1764225642,"startTime":"0","endTime":"0","summary":"证券之星11月27日盘中消息，14点37分特一药业触及涨停板。其所属行业中药目前上涨。领涨股为粤万年青。该股为长寿药NMN，新冠病毒防治，流感概念热股，当日长寿药NMN概念上涨1.71%，新冠病毒防治概念上涨0.41%，流感概念上涨0.25%。11月26日的资金流向数据方面，主力资金净流出2.24亿元，占总成交额11.17%，游资资金净流入1876.73万元，占总成交额0.94%，散户资金净流入2.05亿元，占总成交额10.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700016626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002728","BK0239"],"gpt_icon":0},{"id":"2586300862","title":"11月26日特一药业（002728）龙虎榜数据：机构净买入1593.85万元，北向资金净卖出682.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586300862","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586300862?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:49","pubTimestamp":1764150576,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月26日公布的交易公开信息显示，特一药业因日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年11月26日收盘，特一药业报收于13.61元，上涨1.95%，换手率38.16%，成交量143.79万手，成交额20.05亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入1593.85万元，北向资金合计净卖出682.58万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600027070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770692531751,"stockEarnings":[{"period":"1week","weight":0.1237},{"period":"1month","weight":0.1199},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.3974},{"period":"1year","weight":0.5805},{"period":"ytd","weight":0.2055}],"compareEarnings":[{"period":"1week","weight":0.0267},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0301},{"period":"6month","weight":0.1194},{"period":"1year","weight":0.248},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"特一药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"58139人(较上一季度增加10.11%)","perCapita":"6481股","listingDate":"2014-07-31","address":"广东省江门市台山市台城长兴路9、11号","registeredCapital":"51300万元","survey":" 特一药业集团股份有限公司的主营业务是中成药品、化学制剂药品、化学原料药的研发、生产和销售。公司的主要产品包括止咳宝片、感冒灵颗粒、血塞通分散片、银杏叶分散片、益心舒颗粒、铝碳酸镁咀嚼片、枫蓼肠胃康片、奥美拉唑肠溶胶囊、皮肤病血毒丸、小儿咳喘灵颗粒、金匮肾气片、降糖舒丸、独活寄生颗粒等。","listedPrice":14},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特一药业,002728,特一药业股票,特一药业股票老虎,特一药业股票老虎国际,特一药业行情,特一药业股票行情,特一药业股价,特一药业股市,特一药业股票价格,特一药业股票交易,特一药业股票购买,特一药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}